Post-Chikungunya Chronic Arthralgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria stipulated in the "Diagnosis and Treatment Plan for Chikungunya Fever (2025 Edition)"; 2. The course of the disease is more than one month; 3. The actual clinical prescription conforms to the medication regimen of the observation cohort. 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation period; 2. Joint pain is considered not to be caused by chikungunya fever. 3. Participated in other interventional clinical trials in the past three months; 4. Severe liver and kidney dysfunction (ALT/AST>2×ULN, or eGFR<30 ml/min); 5.Participants who were considered unsuitable for inclusion in the study by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Joint Symptom Evaluation (RAPID3; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of the Traditional Chinese Medicine Syndrome Scale;Chikungunya fever antibody;Blood routine, urine routine, C-reactive protein, erythrocyte sedimentation rate, rheumatoid factor, liver function (Alanine Aminotransferase, Aspartate Aminotransferase, Creatinine, Blood Urea) Nitrogen, Myocardial enzyme spectrum (Creatine Kinase, Creatine kinase-myocardial Band, Lactate Dehydrogenase), hypersensitive troponin, coagulation function (Prothrombin Time, Activated Partial Thromboplastin Time, International Normalized Ratio, Fibrinogen);musculoskeletal B-ultrasound and Magnetic Resonance Imaging; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine